Multiple Myeloma and Hairy Cell Leukemia: A Rare Association or Coincidence?

References

• Al-Fiar F, Meharchand J, Curtis J. Secondary AML 4 years after the diagnosis of HCL: case report and review of the literature. Leuk Res; 1999; 23: 719–21
   PubMed Web of Science ®Google Scholar
• Kurzrock R, Strom S S, Estey E. Second cancer risk in HCL: analysis of 350 patients. JCO 1997; 15: 1803–10
   PubMed Web of Science ®Google Scholar
• Bouroncle B. A. Leukemic reticuloendotheliosis (hairy cell Leukemia). Blood 1979; 53: 412–436
   PubMed Web of Science ®Google Scholar
• Bouroncle B A, Wiseman B K, Doan C A. Leukemic reticuloendotheliosis. Blood 1958; 13: 609–630
   PubMed Web of Science ®Google Scholar
• Golornb H M, Catovsky D, Golde D W. Hairy cell leukemia: a clinical review based on 71 cases. Ann Intern Med. 1978; 89: 677–683
   PubMed Web of Science ®Google Scholar
• Turner A, Kjeldsberg C R. Hairy cell leukemia: a review. Medicine. (Baltimore) 1978; 57: 477–499
   PubMed Web of Science ®Google Scholar
• Bennett J M, Catovsky D, Daniel M-T, et al. Proposal for the classification of chronic (mature) B and T lymphoid leukemias. J Clin Pathol. 1989; 42: 567–584
   PubMed Web of Science ®Google Scholar
• Meijer CJLM, van der Valk P, Jansen J. Hairy cell leukemia: an immunohistochemical and morphometric study. Semin Oncol. 1984; 11: 347–351
   PubMed Web of Science ®Google Scholar
• Katayama I, Yang J PS. Reassignment of a cytochemical test for differential diagnosis of leukemic reticuloendotheliosis. Am J Clin Pathol. 1977; 68: 268–272
   PubMed Web of Science ®Google Scholar
• Yam L T, Jancküa AJ, Li C-Y, Lam W KW. Cytochemistry of tartrate-resistant acid phosphatase: 15 years' experience. Leukemia 1987; 1: 285–288
   PubMed Web of Science ®Google Scholar
• Silverberg E. Cancer statistics. CA Cancer J. Clin. 1985; 35: 19–35
   PubMed Web of Science ®Google Scholar
• Deegan M J. The spectrum of B cell neoplasia. Henry Ford Hosp Med J. 1984; 32: 20–30
   PubMedGoogle Scholar
• Aronwitz J, Band E, Dalai B I. Late transition of hairy cell leukemia to multiple myeloma. Am J. Hematol., 44: 216–217
   PubMed Web of Science ®Google Scholar
• Noseda G, Reiner M. Scali G. Haarzell-leukamie und myelom. Schweiz Med Wochenschr 1980; 110: 1494–1498
   PubMedGoogle Scholar
• Pulford K, Micklem K, Jones T M, Mason D Y. A 72-kd B cell associated surface glycoprotein expressed at high levels in hairy cell leukemia and plasma cell neoplasms. Clin Exp Immunol. 1991; 85: 429–435
   PubMed Web of Science ®Google Scholar
• Mori N, Tsunoda R, Kojima M., Andres T., Kadin M E. Ultrastructural localization of immunoglobulins in hairy cell leukemia. Hum Pathol. 1984; 15: 1042–1047
   PubMed Web of Science ®Google Scholar
• Gazitt Y, Leizerowitz R, Polliack A. Induction of plasmacytoid and hairy cell leukemia features by phorbol esters (TPA) in B-lymphocytic Lymphoma cells: attempted correlation with disease activity. Hematol Oncol. 1988; 6: 307–318
   PubMed Web of Science ®Google Scholar
• Gazitt Y, Polliack A. Phorbol ester induction of plasmacytoid and hairy cell leukemia features in B-cell lymphocytic leukemias: the relation to B-cell differentiation and maturation. Blood Cells 1989; 12: 413–436
   Google Scholar
• Zeigler-Heitbrock H WL, Dorken D, Munker R. In-vitro induction of some features of HCL in CLL and immunocytoma cells. Blut. 1985; 50: 29–31
   PubMedGoogle Scholar
• Algino K M, Hendrix L E, Henderson C A. MM with HC-like features. Am J Clin Pathol 1997; 107: 665–71
   PubMed Web of Science ®Google Scholar
• Arnalich F, Camacho J, Jimenez C. Occurrence of immunoblastic B-cell lymphoma in HCL. Cancer 1987; 59: 1161–1164
   PubMed Web of Science ®Google Scholar
• Vardiman J W, Variakojis D, Golomb H M. HCL: an autopsy study. Cancer 1987; 43: 1339–1349
   Web of Science ®Google Scholar
• Lawlor E, Willoughby R, O'Briain D S, Daly P A. Multiple neoplasms in hairy cell leukemia. Acta Haematol. 1984; 72: 57–60
   PubMed Web of Science ®Google Scholar
• Stewart D J, Keating M J. Second malignancies in HCL. Am J Hematol 1982; 13: 167–69
   PubMed Web of Science ®Google Scholar
• Catovsky D, Costello C, Loukpoulos D, et al. Hairy cell leukemia and myelomatosis: chance association or clinical manifestations of the same B-cell disease spectrum. Blood 1981; 57: 758–763
   PubMed Web of Science ®Google Scholar
• Kampmeier P, Spielberger R, Dickstein J. Increased incidence of second neplasms in patients treated with interferon alpha 2b for HCL: a clinicopathologic assessment. Blood 1994; 83: 2931–8
   PubMed Web of Science ®Google Scholar
• Pawson R, A'Hern R, Catovsky D. Second malignancy in HCL: no evidence of increased incidence after treatment with interferon alpha. Leul Lymphoma 1996; 22: 103–6
   PubMed Web of Science ®Google Scholar
• Anderson K C, Boyd A W, Fisher D C, et al. Hairy cell leukemia: a tumor of pre-plasma cells. Blood 1985; 65: 620–629
   PubMed Web of Science ®Google Scholar
• Robbins B A, Ellison D J, Spinosa J C, et al. Diagnostic application of two-color flow cytometry in 161 cases of hairy cell leukemia. Blood 1993; 82: 177–1287
   Google Scholar
• Jansen J, Le Bien T W, Kersey J H. The phenotype of neoplastic cells in hairy cell leukemia studied with monoclonal antibodies. Blood 1982; 59: 609–614
   PubMed Web of Science ®Google Scholar
• Hassan I B, Hagberg H, Sundstrom C. Immunopheno-type of hairy cell leukemia. Eur J Haematol. 1990; 45: 172–176
   PubMed Web of Science ®Google Scholar
• Caligaris-Cappio F, Janossy G, Campana D, et al. Lineage relationship of chronic lymphocytic leukemia and hairy cell leukemia: a study with TPA. Leuk Res. 1984; 8: 567–578
   PubMed Web of Science ®Google Scholar
• Kurzrock R, Talpaz M, Gutterman J U. Hairy cell leukemia: review of treatment. Br J Haematol. 1991; 79: 17–20
   PubMed Web of Science ®Google Scholar
• Saven A, Piro L. Newer purine analogues for the treatment of hairy cell leukemia. N Engl J Med. 1994; 330: 691–697
   PubMed Web of Science ®Google Scholar
• Thaler J, Denz H, Dietze O, et al. Immunohistological assesment of bone marrow biopsies from patients with hairy cell leukemia: changes following treatment with alpha-2-interferon and deoxycoformycin. Leuk Res. 1989; 13: 377–383
   PubMed Web of Science ®Google Scholar
• Kyle RA. Newer approaches to the management of multiple myeloma. Cancer 1993; 72(suppl)3489–3494
   PubMed Web of Science ®Google Scholar
• Cawley J C, Burns G F, Hayhoe F G. A Chronic lymphoproliferative disorder with distinctive features: a distinct variant of hairy-cell leukemia. Leuk Res. 1980; 4: 547–559
   PubMed Web of Science ®Google Scholar
• Sun T, Susin M, Shevde N, Teichberg S. Hybrid form of hairy cell leukemia and chronic lymphocytic leukemia. Hematol Oncol. 1990; 8: 283–294
   PubMed Web of Science ®Google Scholar
• Mintz G, Robles-Saavedra E J, Enriquez R D, Jimenez F J, Juan M L. Hemarthrosis as the presenting manifestation of true myeloma joint disease. Arthritis Rheum. 1978; 21(1)148–51
   PubMed Web of Science ®Google Scholar